|
½ÃÀ庸°í¼
European Markets for Parkinson's Disease Therapeutics
| ¸®¼Ä¡»ç |
Frost & Sullivan |
| ¹ßÇàÀÏ |
2009³â 05¿ù |
»óǰÄÚµå |
90173 |
| ÆäÀÌÁö Á¤º¸ |
71 Pages |
| °¡°Ý |
|
|
Abstract
This research service discusses the market for Parkinson' s disease. It
analyses the various opportunities, recent developments, drug classes and
gives a revenue forecasts.
Table of Contents
1. EXECUTIVE SUMMARY
Summary of Findings
2. PARKINSON' S DISEASE
Disease Overview
- Scope
- Overview
- Prevalence and Incidence
- Clinical Classification
- Diagnosis
Treatment Overview
- Guidelines for Parkinson' s Disease Management
- Surgical and Related Options
- Product and Pricing Analysis
3. MARKET FOR PARKINSON' S DISEASE THERAPEUTICS
Market Engineering Analysis
- Market Overview
- Market Engineering Measurements
Market Dynamics
- Challenges
- Market Drivers
- Market Restraints
Market Forecasts and Trends
- Disease Progression
- Developments
- Patient Forecasts
- Revenue Forecasts
4. DOPAMINE AGONISTS MARKET
Current Drugs
- Dosage and Pricing Analysis
- Product Analysis
Market Dynamics
- Market Drivers
- Market Restraints
5. LEVODOPA/CARBIDOPA MARKET
Current Drugs
- Dosage and Pricing Analysis
- Product Analysis
Market Dynamics
- Market Drivers
- Market Restraints
6. OTHERS
Current Products and Pricing
- COMT Inhibitors
- MAO-B Inhibitors
- Fixed Dose Combinations
Market Dynamics
- Market Drivers
- Market Restraints
Pipeline Analysis
- Products in Phase III
- Products in Phase II
7. DECISION SUPPORT DATABASES
List of Tables
- Population Aged 65 Years and above
- Female Population Aged 65 Years and above
- Male Population Aged 65 Years and above
- Number of Physicians
- Hospital Discharge from Cerebrovascular Disease
|